Meeting
2019 ASCO Quality Care Symposium
A budget impact model for biosimilar myeloid growth factors (MGFs) within the Oncology Care Model (OCM): An oncology group practice perspective.
Authors
Ali McBride
University of Arizona Cancer Center, Tucson, AZ
Ali McBride, Weijia Wang, Edward C. Li, Sanjeev Balu, Kim Campbell
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cost, Value, and Policy; Health Equity and Disparities
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 37, 2019 (suppl 27; abstr 108)
DOI
10.1200/JCO.2019.37.27_suppl.108
Abstract #
108
Poster Bd #
H7
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Quality Care Symposium
Can we keep patients home? Decreasing hospitalizations in the oral chemotherapy patient.
First Author: Michelle Rene Karlin
Poster
2019 ASCO Annual Meeting
Cost-minimization analysis for biosimilar pegfilgrastim in the prophylaxis of chemotherapy induced (Febrile) neutropenia and expanded access based on budget neutral basis.
First Author: Weijia Wang
Poster
2019 ASCO Annual Meeting
Clinical and economic outcomes of pegfilgrastim in metastatic colorectal cancer.
First Author: Lalan S. Wilfong
Poster
2024 ASCO Annual Meeting
Medicare reimbursement trends of biological reference agents and their biosimilars.
First Author: John Albaugh